AWA
ARS Wealth Advisors Portfolio holdings
AUM
$556M
Turnover
17.12%
1-Year Est. Return
30.03%
This Fund
S&P 500
This Quarter
Est. Return
-1.25%
1 Year Est. Return
+30.03%
3 Year Est. Return
+61.81%
5 Year Est. Return
+96.2%
10 Year Est. Return
–
AUM
$268M
AUM Growth
-$1.04M
(-0.38%)
Cap. Flow
+$3.98M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
61.7%
Holding
125
New
6
Increased
48
Reduced
48
Closed
9
Avg Time Held
2.4
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$6.49M |
| 2 |
iShares MSCI USA Equal Weighted ETF
EUSA
|
+$4.12M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.62M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$930K |
| 5 |
MON
Monsanto Co
MON
|
+$726K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Pharmaceuticals ETF
IHE
|
+$2.52M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.51M |
| 3 |
Compass Minerals
CMP
|
+$1.49M |
| 4 |
iShares US Transportation ETF
IYT
|
+$1.45M |
| 5 |
iShares Core High Dividend ETF
HDV
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 60.71% |
| 2 | Financials | 7.7% |
| 3 | Technology | 6.86% |
| 4 | Consumer Staples | 6.16% |
| 5 | Healthcare | 4.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CELG
76
DELISTED
Celgene Corp
CELG
| $406K | 0.15% |
4,546
-4,250
| -48% | -$408K |
2016 Q3
6 quarters
|
|
77
Citigroup
C
$207B
| $403K | 0.15% |
5,974
+3,228
| +118% | +$243K |
2017 Q4
1 quarter
|
|
78
AbbVie
ABBV
$502B
| $399K | 0.15% |
4,215
+916
| +28% | +$101K |
2017 Q3
2 quarters
|
|
79
J.M. Smucker
SJM
$13B
| $381K | 0.14% |
3,072
| – | – |
2014 Q2
15 quarters
|
|
80
Vanguard Morningstar Total Stock Market ETF
VTI
$694B
| $377K | 0.14% |
2,777
+336
| +14% | +$47.1K |
2017 Q2
3 quarters
|
|
81
IBM
IBM
$216B
| $373K | 0.14% |
2,540
-705
| -22% | -$107K |
2016 Q2
7 quarters
|
|
82
PayPal
PYPL
$47.8B
| $352K | 0.13% |
4,640
-895
| -16% | -$71K |
2016 Q3
6 quarters
|
|
83
Invesco QQQ Trust
QQQ
$488B
| $335K | 0.12% |
2,094
-38
| -2% | -$6.28K |
2016 Q2
7 quarters
|
|
84
Salesforce
CRM
$193B
| $318K | 0.12% |
2,735
-550
| -17% | -$63.2K |
2016 Q3
6 quarters
|
|
|
RTN
85
DELISTED
Raytheon Company
RTN
| $304K | 0.11% |
1,407
+4
| +0.3% | +$828 |
2016 Q4
5 quarters
|
|
86
Berkshire Hathaway Class A
BRK.A
$1.12T
| $299K | 0.11% |
1
| – | – |
2016 Q2
7 quarters
|
|
87
Goldman Sachs
GS
$255B
| $299K | 0.11% |
1,188
+9
| +0.8% | +$2.34K |
2017 Q1
4 quarters
|
|
88
Williams Companies
WMB
$89.6B
| $294K | 0.11% |
11,809
-198
| -2% | -$5.84K |
2016 Q3
6 quarters
|
|
89
State Street SPDR S&P 500 ETF Trust
SPY
$812B
| $286K | 0.11% |
+1,086
| New | +$296K |
2018 Q1
0 quarters
|
|
90
US Bancorp
USB
$87.2B
| $282K | 0.11% |
5,579
+4
| +0.1% | +$219 |
2016 Q2
7 quarters
|
|
91
iShares Core S&P 500 ETF
IVV
$886B
| $280K | 0.1% |
1,057
-75
| -7% | -$20.6K |
2014 Q4
13 quarters
|
|
92
CSX Corp
CSX
$88.7B
| $273K | 0.1% |
14,676
| – | – |
2017 Q1
4 quarters
|
|
93
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
| $272K | 0.1% |
+4,653
| New | +$275K |
2018 Q1
0 quarters
|
|
94
DaVita
DVA
$11.6B
| $270K | 0.1% |
4,100
| – | – |
2013 Q4
17 quarters
|
|
95
SPDR Gold Trust
GLD
$138B
| $268K | 0.1% |
2,128
-6
| -0.3% | -$757 |
2013 Q4
17 quarters
|
|
96
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.31B
| $259K | 0.1% |
3,513
-1,185
| -25% | -$87.4K |
2013 Q4
17 quarters
|
|
97
Vanguard Morningstar Mid-Cap ETF
VO
$105B
| $259K | 0.1% |
6,720
-2,668
| -28% | -$105K |
2013 Q4
17 quarters
|
|
98
Bristol-Myers Squibb
BMY
$120B
| $255K | 0.1% |
4,025
+144
| +4% | +$9.26K |
2015 Q4
9 quarters
|
|
99
State Street Industrial Select Sector SPDR ETF
XLI
$30.4B
| $251K | 0.09% |
3,385
-2,670
| -44% | -$206K |
2017 Q1
4 quarters
|
|
100
Vanguard Consumer Staples ETF
VDC
$7.83B
| $248K | 0.09% |
1,821
-1,569
| -46% | -$222K |
2017 Q1
4 quarters
|
|
Similar funds
HFA
PPSG
PMAS
APA
HH
SA
EMG
SCM
ARS Wealth Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ARS Wealth Advisors held 125 positions worth $268M, down 0.38% from $270M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
ARS Wealth Advisors's Q1 2018 filing shows 6 new, 48 increased, 48 reduced and 9 closed positions. Its largest new stake was Monsanto Co: 6,033 shares worth $704K. The largest sale was iShares US Pharmaceuticals ETF, an estimated $2.52M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 60% a quarter earlier, followed by Financials and Technology.
- ARS Wealth Advisors's largest Q1 2018 buy was Monsanto Co: 6,033 shares worth $704K.
- ARS Wealth Advisors added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q1 2018, an estimated $6.49M increase.
- ARS Wealth Advisors's biggest Q1 2018 reduction was iShares US Pharmaceuticals ETF, cutting an estimated $2.52M.
- ARS Wealth Advisors fully exited Compass Minerals in Q1 2018, selling an estimated $1.49M.
- ARS Wealth Advisors's ten largest holdings make up 62% of its $268M portfolio in Q1 2018.
- ARS Wealth Advisors opened 6 new positions and closed 9 in Q1 2018.
- ARS Wealth Advisors's portfolio value fell 0.38% quarter-over-quarter to $268M.
Based on ARS Wealth Advisors's 13F filing for Q1 2018, filed 11 Jun 2021.